跳至主要内容
临床试验/NCT04148417
NCT04148417进行中(未招募)不适用

Clinical Study of the Solo+ Tympanostomy Tube Device

AventaMed DAC2 个研究点 分布在 1 个国家目标入组 27 人开始时间: 2021年2月9日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
AventaMed DAC
入组人数
27
试验地点
2
主要终点
Rate of Adverse Events

研究概览

简要总结

The objective of this study is to evaluate the safety and performance of the Solo+ Tympanostomy Tube Device for the placement of tympanostomy tubes (grommets) in paediatric patients undergoing a tympanostomy procedure

详细描述

The study will be a multi-site, prospective, treatment-only study of the Solo+ Tympanostomy Tube Device. Patients will already have a scheduled tympanostomy procedure.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
6 Months 至 15 Years(Child)
性别
All
接受健康志愿者
否

入选标准

  • •Listed for bilateral tympanostomy tube insertion

排除标准

  • •Anatomy that precludes sufficient visualisation of both the left and right eardrum
  • •Narrow ear canals
  • •Anatomy that precludes safe access to both the left and right eardrum
  • •Membrane >25% sclerosis
  • •Congenital or craniofacial abnormalities
  • •No available baseline audiometry and tympanometry

研究组 & 干预措施

Solo+ Tympanostomy Tube Device

Experimental

The Solo+ Tympanostomy Tube Device is a disposable surgical tool designed to deliver a tympanostomy tube (grommet) into the tympanic membrane of patients undergoing a tympanostomy tube placement procedure

干预措施: Solo+ Tympanostomy Tube Device (Device)

结局指标

主要结局

Rate of Adverse Events

时间窗: 24 months

The number and type of Adverse Events

Successful delivery of the tympanostomy tube by the Solo+ Tympanostomy Tube Device

时间窗: Intra-operative

The number of ears in which the Solo Tympanostomy Tube Device tube is placed

次要结局

未报告次要终点

研究者

发起方
AventaMed DAC
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验